List of insiders holdings for Sage Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | BIOGEN INC. Biogen MA Inc. 10% Owner | 2025-01-10 17:34:57 | 6,241,473 0 | 6,241,473 | Form 13D |
| 2 | NELSEN ROBERT Director | 2015-11-12 10:26:45 | 133,361 1,624,699 | 1,758,060 | Form 4 |
| 3 | Third Rock Ventures II L.P. Third Rock Ventures GP II L.P. TRV GP II LLC LEVIN MARK J TEPPER ROBERT I 10% Owner | 2018-02-13 16:10:13 | 899,023 0 | 899,023 | Form 13G |
| 4 | Greene Barry E President and CEO | 2025-04-11 16:09:39 | 100,169 0 | 100,169 | Form 4 |
| 5 | IGUCHI KIMI CFO & Treasurer | 2024-08-07 16:05:00 | 81,405 0 | 81,405 | Form 4 |
| 6 | Benecchi Christopher Chief Operating Officer | 2025-04-11 16:09:54 | 48,428 0 | 48,428 | Form 4 |
| 7 | Anderson Thomas See Remarks | 2017-02-08 16:56:55 | 40,000 0 | 40,000 | Form 4 |
| 8 | Gault Laura Chief Medical Officer | 2025-02-14 16:26:57 | 34,649 0 | 34,649 | Form 4 |
| 9 | Shiferman Gregory L. See Remarks | 2025-06-26 16:02:20 | 30,950 0 | 30,950 | Form 4 |
| 10 | Quirk Michael C. See Remarks | 2025-06-26 16:02:27 | 30,461 0 | 30,461 | Form 4 |
| 11 | Cook Anne Marie SVP, GC & Secretary | 2024-08-07 16:04:48 | 24,040 0 | 24,040 | Form 4 |
| 12 | Barrett Elizabeth A. Director | 2025-06-13 16:13:24 | 21,500 0 | 21,500 | Form 4 |
| 13 | COLA MICHAEL F Director | 2025-06-13 16:13:36 | 21,500 0 | 21,500 | Form 4 |
| 14 | Federer Jessica Director | 2025-06-13 16:13:47 | 21,500 0 | 21,500 | Form 4 |
| 15 | FRATES JAMES M Director | 2025-06-13 16:13:57 | 21,500 0 | 21,500 | Form 4 |
| 16 | Golumbeski George Director | 2025-06-13 16:14:04 | 21,500 0 | 21,500 | Form 4 |
| 17 | Germano Geno J Director | 2025-06-13 16:14:14 | 21,500 0 | 21,500 | Form 4 |
| 18 | Cloonan Michael Chief Business Officer | 2021-02-12 16:01:21 | 19,000 0 | 19,000 | Form 4 |
| 19 | Robichaud Albert Chief Scientific Officer | 2023-02-15 16:47:01 | 16,720 0 | 16,720 | Form 4 |
| 20 | PIEN HOWARD H Director | 2016-06-24 11:34:21 | 13,922 0 | 13,922 | Form 4 |
| 21 | Kanes Stephen Chief Medical Officer | 2021-10-21 16:02:51 | 13,471 0 | 13,471 | Form 4 |
| 22 | Barrett Elizabeth Director | 2024-06-11 16:57:31 | 12,500 0 | 12,500 | Form 4 |
| 23 | JONAS JEFFREY M Director | 2024-06-11 16:58:49 | 12,500 0 | 12,500 | Form 4 |
| 24 | STARR KEVIN P Director | 2023-06-16 16:05:30 | 10,000 0 | 10,000 | Form 4 |
| 25 | Nayak Asha Director | 2019-06-06 16:02:45 | 10,000 0 | 10,000 | Form 4 |
| 26 | PAUL STEVEN M Director | 2024-01-04 16:07:48 | 3,971 0 | 3,971 | Form 4 |
| 27 | Arch Venture Fund VII LP ARCH Venture Partners VII L.P. ARCH Venture Partners VII LLC CRANDELL KEITH BYBEE CLINTON 10% Owner | 2016-02-11 09:57:00 | 0 0 | 0 | Form 13G |